GH
JAZZ icon

GAM Holding’s Jazz Pharmaceuticals JAZZ Stock Holding History

GAM Holding’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,302
Closed -$1.69M – 442
2019
Q4 		$1.69M Sell
11,302
-4,463
-28% -$607K 0.08% 249
2019
Q3 		$2.02M Sell
15,765
-2,135
-12% -$286K 0.09% 246
2019
Q2 		$2.55M Sell
17,900
-168
-0.9% -$22.6K 0.1% 223
2019
Q1 		$2.58M Buy
18,068
+3,058
+20% +$399K 0.11% 217
2018
Q4 		$1.86M Sell
15,010
-28,868
-66% -$4.28M 0.09% 240
2018
Q3 		$7.38M Buy
43,878
+5,145
+13% +$885K 0.27% 100
2018
Q2 		$6.67M Buy
38,733
+433
+1% +$70.8K 0.23% 114
2018
Q1 		$5.78M Sell
38,300
-364
-0.9% -$53.4K 0.2% 139
2017
Q4 		$5.21M Buy
+38,664
New +$5.36M 0.16% 167

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

GAM Holding's JAZZ Position: Q1 2020 in Review

GAM Holding sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2020, closing a stake of 11,302 shares — an estimated $1.69M sold.

GAM Holding first reported a position in JAZZ in Q4 2017 and held it in 9 quarters. The position peaked at $7.38M in Q3 2018. 407 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

  • GAM Holding reported no remaining Jazz Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • GAM Holding sold 11,302 Jazz Pharmaceuticals shares in Q1 2020, an estimated $1.69M.
  • GAM Holding first reported a position in Jazz Pharmaceuticals in Q4 2017 and held it in 9 quarters.
  • GAM Holding's Jazz Pharmaceuticals position peaked at $7.38M in Q3 2018.
  • 407 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on GAM Holding's 13F filing for Q1 2020, filed 12 May 2020.